As per the agreement, Teva subsidiary Salomon, Levin, Elstein will not only distribute Canndoc’s products in Israel, but also seek to “provide logistics capability for exporting Canndoc’s products to countries that support regulations for the sale and distribution of cannabis products for medical use,” as soon as local regulations allow for it, Canndoc, a subsidiary of publicly traded company InterCure, explained.
Adding to these notes, Canndoc’s Chairman Ehud Barak said, “Our agreement with S.L.E., Israel’s leading company in distributing medical products, creates a complete supporting platform for supplying Canndoc’s GMP products to any location in Israel and for countries with similar regulations… Through its S.L.E.
The initial agreement will span for three years, but a term to automatically extend it for two-year periods at a time is included in the deal.While this is not the first deal between a big pharma company and a cannabis-related business, it is among the couple notable ones to date – pharma is being careful with its approach to marijuana, hemp, CBD and related industries.The other big deal announced to date: a development and distribution deal between Novartis and Tilray.
Johnson & Johnson has also been getting its feet wet in the proverbial canna-pond. Back in 2017, the company’s incubator, JLABS @ Toronto,Beyond specific deals, a few big pharma companies have
Please!, the pharmaceutical companies have been growing & producing marijuana and other drugs for two hundred or more years this is new to the public because all they ever are told us lies to misdirect & misinform them lol
Ex-Pfizer, I cringe at equating Teva, mostly generics, w/large innovative pharma - Teva has signed w/a cannabis firm '..from market cap to revenue, Teva is one of the largest pharma companies in the world;..biggest generic drug manufacturer in the globe'
What are the cGMP regs for cannabis products? They don't yet exist. Someone is being conned. CNBC